{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:23:56Z","timestamp":1792736636641,"version":"4.5.0"},"reference-count":184,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1038\/s41574-024-01049-w","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T11:02:15Z","timestamp":1729854135000},"page":"77-91","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Metformin in gestational diabetes: physiological actions and clinical applications"],"prefix":"10.1038","volume":"21","author":[{"given":"Taitum","family":"Mason","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Alesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter","family":"Vanky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena J.","family":"Teede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7356-4523","authenticated-orcid":false,"given":"Aya","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,25]]},"reference":[{"key":"1049_CR1","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.2337\/dc09-S062","volume":"32","author":"American Diabetes Association.","year":"2009","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 32, S62\u2013S67 (2009).","journal-title":"Diabetes Care"},{"key":"1049_CR2","doi-asserted-by":"publisher","unstructured":"Zhang, K. et al. Metabolic diseases and healthy aging: identifying environmental and behavioral risk factors and promoting public health. Front. Public Health https:\/\/doi.org\/10.3389\/fpubh.2023.1253506 (2023).","DOI":"10.3389\/fpubh.2023.1253506"},{"key":"1049_CR3","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.2337\/dc23-S002","volume":"46","author":"NA ElSayed","year":"2022","unstructured":"ElSayed, N. A. et al. Classification and diagnosis of diabetes: standards of care in diabetes \u2014 2023. Diabetes Care 46, S19\u2013S40 (2022).","journal-title":"Diabetes Care"},{"key":"1049_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-019-0098-8","volume":"5","author":"HD McIntyre","year":"2019","unstructured":"McIntyre, H. D. et al. Gestational diabetes mellitus. Nat. Rev. Dis. Prim. 5, 47 (2019).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1049_CR5","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3109\/14767058.2011.587921","volume":"25","author":"A Jiwani","year":"2012","unstructured":"Jiwani, A. et al. Gestational diabetes mellitus: results from a survey of country prevalence and practices. J. Matern. Fetal Neonatal Med. 25, 600\u2013610 (2012).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"1049_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109050","volume":"183","author":"H Wang","year":"2022","unstructured":"Wang, H. et al. IDF Diabetes Atlas: estimation of global and regional gestational diabetes mellitus prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group\u2019s Criteria. Diabetes Res. Clin. Pract. 183, 109050 (2022).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1049_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-023293","volume":"9","author":"TJ Cade","year":"2019","unstructured":"Cade, T. J., Polyakov, A. & Brennecke, S. P. Implications of the introduction of new criteria for the diagnosis of gestational diabetes: a health outcome and cost of care analysis. BMJ Open 9, e023293 (2019).","journal-title":"BMJ Open"},{"key":"1049_CR8","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.2337\/dc18-1226","volume":"42","author":"TM Dall","year":"2019","unstructured":"Dall, T. M. et al. The economic burden of elevated blood glucose levels in 2017: diagnosed and undiagnosed diabetes, gestational diabetes mellitus, and prediabetes. Diabetes Care 42, 1661\u20131668 (2019).","journal-title":"Diabetes Care"},{"key":"1049_CR9","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","volume":"60","author":"G Rena","year":"2017","unstructured":"Rena, G., Hardie, D. G. & Pearson, E. R. The mechanisms of action of metformin. Diabetologia 60, 1577\u20131585 (2017).","journal-title":"Diabetologia"},{"key":"1049_CR10","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1001\/archinte.168.19.2088","volume":"168","author":"GC Alexander","year":"2008","unstructured":"Alexander, G. C., Sehgal, N. L., Moloney, R. M. & Stafford, R. S. National trends in treatment of type 2 diabetes mellitus, 1994\u20132007. Arch. Intern. Med. 168, 2088\u20132094 (2008).","journal-title":"Arch. Intern. Med."},{"key":"1049_CR11","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1097\/FPC.0b013e32834c0010","volume":"21","author":"MM Christensen","year":"2011","unstructured":"Christensen, M. M. et al. The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c. Pharmacogenet. Genomics 21, 837\u2013850 (2011).","journal-title":"Pharmacogenet. Genomics"},{"key":"1049_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev.pharmtox.47.120505.105304","volume":"47","author":"DG Hardie","year":"2007","unstructured":"Hardie, D. G. AMP-activated protein kinase as a drug target. Annu. Rev. Pharmacol. Toxicol. 47, 185\u2013210 (2007).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"1049_CR13","doi-asserted-by":"publisher","first-page":"212523","DOI":"10.7573\/dic.212523","volume":"7","author":"G Priya","year":"2018","unstructured":"Priya, G. & Kalra, S. Metformin in the management of diabetes during pregnancy and lactation. Drugs Context 7, 212523 (2018).","journal-title":"Drugs Context"},{"key":"1049_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2165\/00003088-199630050-00003","volume":"30","author":"AJ Scheen","year":"1996","unstructured":"Scheen, A. J. Clinical pharmacokinetics of metformin. Clin. Pharmacokinet. 30, 359\u2013371 (1996).","journal-title":"Clin. Pharmacokinet."},{"key":"1049_CR15","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1001\/jama.2014.15298","volume":"312","author":"SE Inzucchi","year":"2014","unstructured":"Inzucchi, S. E., Lipska, K. J., Mayo, H., Bailey, C. J. & McGuire, D. K. Metformin in patients with type 2 diabetes and kidney disease: a systematic review. JAMA 312, 2668\u20132675 (2014).","journal-title":"JAMA"},{"key":"1049_CR16","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/j.1365-2710.2010.01192.x","volume":"36","author":"IR van Berlo-van de Laar","year":"2011","unstructured":"van Berlo-van de Laar, I. R., Vermeij, C. G. & Doorenbos, C. J. Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements. J. Clin. Pharm. Ther. 36, 376\u2013382 (2011).","journal-title":"J. Clin. Pharm. Ther."},{"key":"1049_CR17","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.beem.2010.05.002","volume":"24","author":"D Simmons","year":"2010","unstructured":"Simmons, D. Metformin treatment for type 2 diabetes in pregnancy? Best Pract. Res. Clin. Endocrinol. Metab. 24, 625\u2013634 (2010).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"1049_CR18","first-page":"4059","volume":"81","author":"K Cusi","year":"1996","unstructured":"Cusi, K., Consoli, A. & DeFronzo, R. A. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 81, 4059\u20134067 (1996).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1049_CR19","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"Zhou, G. et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167\u20131174 (2001).","journal-title":"J. Clin. Invest."},{"key":"1049_CR20","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","volume":"20","author":"M Foretz","year":"2014","unstructured":"Foretz, M., Guigas, B., Bertrand, L., Pollak, M. & Viollet, B. Metformin: from mechanisms of action to therapies. Cell Metab. 20, 953\u2013966 (2014).","journal-title":"Cell Metab."},{"key":"1049_CR21","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41574-019-0242-2","volume":"15","author":"M Foretz","year":"2019","unstructured":"Foretz, M., Guigas, B. & Viollet, B. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus. Nat. Rev. Endocrinol. 15, 569\u2013589 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1049_CR22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nature11808","volume":"494","author":"RA Miller","year":"2013","unstructured":"Miller, R. A. et al. Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP. Nature 494, 256\u2013260 (2013).","journal-title":"Nature"},{"key":"1049_CR23","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/s41591-018-0159-7","volume":"24","author":"RW Hunter","year":"2018","unstructured":"Hunter, R. W. et al. Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase. Nat. Med. 24, 1395\u20131406 (2018).","journal-title":"Nat. Med."},{"key":"1049_CR24","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1126\/science.1120781","volume":"310","author":"RJ Shaw","year":"2005","unstructured":"Shaw, R. J. et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310, 1642\u20131646 (2005).","journal-title":"Science"},{"key":"1049_CR25","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3390\/biom11060873","volume":"11","author":"X Guo","year":"2021","unstructured":"Guo, X. et al. Metformin targets Foxo1 to control glucose homeostasis. Biomolecules 11, 873 (2021).","journal-title":"Biomolecules"},{"key":"1049_CR26","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ncb2329","volume":"13","author":"MM Mihaylova","year":"2011","unstructured":"Mihaylova, M. M. & Shaw, R. J. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat. Cell Biol. 13, 1016\u20131023 (2011).","journal-title":"Nat. Cell Biol."},{"key":"1049_CR27","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1172\/JCI40671","volume":"120","author":"M Foretz","year":"2010","unstructured":"Foretz, M. et al. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1\/AMPK pathway via a decrease in hepatic energy state. J. Clin. Invest. 120, 2355\u20132369 (2010).","journal-title":"J. Clin. Invest."},{"key":"1049_CR28","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature13270","volume":"510","author":"AK Madiraju","year":"2014","unstructured":"Madiraju, A. K. et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510, 542\u2013546 (2014).","journal-title":"Nature"},{"key":"1049_CR29","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41574-023-00833-4","volume":"19","author":"M Foretz","year":"2023","unstructured":"Foretz, M., Guigas, B. & Viollet, B. Metformin: update on mechanisms of action and repurposing potential. Nat. Rev. Endocrinol. 19, 460\u2013476 (2023).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1049_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41586-022-04431-8","volume":"603","author":"T Ma","year":"2022","unstructured":"Ma, T. et al. Low-dose metformin targets the lysosomal AMPK pathway through PEN2. Nature 603, 159\u2013165 (2022).","journal-title":"Nature"},{"key":"1049_CR31","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/jcp.22410","volume":"226","author":"JO Lee","year":"2011","unstructured":"Lee, J. O. et al. Metformin induces Rab4 through AMPK and modulates GLUT4 translocation in skeletal muscle cells. J. Cell. Physiol. 226, 974\u2013981 (2011).","journal-title":"J. Cell. Physiol."},{"key":"1049_CR32","doi-asserted-by":"publisher","first-page":"17853","DOI":"10.1074\/jbc.RA118.005040","volume":"293","author":"S Mafakheri","year":"2018","unstructured":"Mafakheri, S. et al. AKT and AMP-activated protein kinase regulate TBC1D1 through phosphorylation and its interaction with the cytosolic tail of insulin-regulated aminopeptidase IRAP. J. Biol. Chem. 293, 17853\u201317862 (2018).","journal-title":"J. Biol. Chem."},{"key":"1049_CR33","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1210\/me.2008-0111","volume":"22","author":"J St\u00f6ckli","year":"2008","unstructured":"St\u00f6ckli, J. et al. Regulation of glucose transporter 4 translocation by the Rab guanosine triphosphatase-activating protein AS160\/TBC1D4: role of phosphorylation and membrane association. Mol. Endocrinol. 22, 2703\u20132715 (2008).","journal-title":"Mol. Endocrinol."},{"key":"1049_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrm.2017.89","volume":"19","author":"RA Haeusler","year":"2018","unstructured":"Haeusler, R. A., McGraw, T. E. & Accili, D. Biochemical and cellular properties of insulin receptor signalling. Nat. Rev. Mol. Cell Biol. 19, 31\u201344 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1049_CR35","doi-asserted-by":"publisher","unstructured":"Kim, C.-W., Lee, J. M. & Park, S. W. Divergent roles of the regulatory subunits of class IA PI3K. Front. Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2023.1152579 (2024).","DOI":"10.3389\/fendo.2023.1152579"},{"key":"1049_CR36","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.66942","volume":"10","author":"AL Kearney","year":"2021","unstructured":"Kearney, A. L. et al. Akt phosphorylates insulin receptor substrate to limit PI3K-mediated PIP3 synthesis. eLife 10, e66942 (2021).","journal-title":"eLife"},{"key":"1049_CR37","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/ncb839","volume":"4","author":"K Inoki","year":"2002","unstructured":"Inoki, K., Li, Y., Zhu, T., Wu, J. & Guan, K.-L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4, 648\u2013657 (2002).","journal-title":"Nat. Cell Biol."},{"key":"1049_CR38","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","volume":"30","author":"DM Gwinn","year":"2008","unstructured":"Gwinn, D. M. et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30, 214\u2013226 (2008).","journal-title":"Mol. Cell"},{"key":"1049_CR39","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim, J., Kundu, M., Viollet, B. & Guan, K.-L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13, 132\u2013141 (2011).","journal-title":"Nat. Cell Biol."},{"key":"1049_CR40","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1007\/s00125-015-3632-6","volume":"58","author":"G Xu","year":"2015","unstructured":"Xu, G. et al. Intestinal mTOR regulates GLP-1 production in mouse L cells. Diabetologia 58, 1887\u20131897 (2015).","journal-title":"Diabetologia"},{"key":"1049_CR41","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.2337\/db18-0451","volume":"67","author":"LC Page","year":"2018","unstructured":"Page, L. C., Gastaldelli, A., Gray, S. M., D\u2019Alessio, D. A. & Tong, J. Interaction of GLP-1 and ghrelin on glucose tolerance in healthy humans. Diabetes 67, 1976\u20131985 (2018).","journal-title":"Diabetes"},{"key":"1049_CR42","first-page":"45","volume":"15","author":"MM Adeva-Andany","year":"2019","unstructured":"Adeva-Andany, M. M., Funcasta-Calder\u00f3n, R., Fern\u00e1ndez-Fern\u00e1ndez, C., Castro-Quintela, E. & Carneiro-Freire, N. Metabolic effects of glucagon in humans. J. Clin. Transl. Endocrinol. 15, 45\u201353 (2019).","journal-title":"J. Clin. Transl. Endocrinol."},{"key":"1049_CR43","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.yhbeh.2017.05.004","volume":"93","author":"AM Blanco","year":"2017","unstructured":"Blanco, A. M., Bertucci, J. I., Valenciano, A. I., Delgado, M. J. & Unniappan, S. Ghrelin suppresses cholecystokinin (CCK), peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) in the intestine, and attenuates the anorectic effects of CCK, PYY and GLP-1 in goldfish (Carassius auratus). Hormones Behav. 93, 62\u201371 (2017).","journal-title":"Hormones Behav."},{"key":"1049_CR44","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1056\/NEJMoa030204","volume":"349","author":"RL Batterham","year":"2003","unstructured":"Batterham, R. L. et al. Inhibition of food intake in obese subjects by peptide YY3\u201336. N. Engl. J. Med. 349, 941\u2013948 (2003).","journal-title":"N. Engl. J. Med."},{"key":"1049_CR45","doi-asserted-by":"publisher","unstructured":"Gao, Y. & Tian, T. mTOR signaling pathway and gut microbiota in various disorders: mechanisms and potential drugs in pharmacotherapy. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms241411811 (2023).","DOI":"10.3390\/ijms241411811"},{"key":"1049_CR46","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/gutjnl-2012-303839","volume":"63","author":"N-R Shin","year":"2014","unstructured":"Shin, N.-R. et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63, 727\u2013735 (2014).","journal-title":"Gut"},{"key":"1049_CR47","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2337\/dc16-1324","volume":"40","author":"J De La Cuesta-Zuluaga","year":"2017","unstructured":"De La Cuesta-Zuluaga, J. et al. Metformin is associated with higher relative abundance of mucin-degrading Akkermansia muciniphila and several short-chain fatty acid-producing microbiota in the gut. Diabetes Care 40, 54\u201362 (2017).","journal-title":"Diabetes Care"},{"key":"1049_CR48","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cmet.2017.09.019","volume":"27","author":"PV Bauer","year":"2018","unstructured":"Bauer, P. V. et al. Metformin alters upper small intestinal microbiota that impact a glucose-SGLT1-sensing glucoregulatory pathway. Cell Metab. 27, 101\u2013117.e5 (2018).","journal-title":"Cell Metab."},{"key":"1049_CR49","doi-asserted-by":"publisher","unstructured":"Wang, S. & Yadav, H. Metformin reduces Clostridium difficile infection. FASEB J. https:\/\/doi.org\/10.1096\/fasebj.2021.35.S1.03618 (2021).","DOI":"10.1096\/fasebj.2021.35.S1.03618"},{"key":"1049_CR50","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nature15766","volume":"528","author":"K Forslund","year":"2015","unstructured":"Forslund, K. et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528, 262\u2013266 (2015).","journal-title":"Nature"},{"key":"1049_CR51","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nm.4345","volume":"23","author":"H Wu","year":"2017","unstructured":"Wu, H. et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat. Med. 23, 850\u2013858 (2017).","journal-title":"Nat. Med."},{"key":"1049_CR52","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cell.2013.12.016","volume":"156","author":"F De Vadder","year":"2014","unstructured":"De Vadder, F. et al. Microbiota-generated metabolites promote metabolic benefits via gut\u2013brain neural circuits. Cell 156, 84\u201396 (2014).","journal-title":"Cell"},{"key":"1049_CR53","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1681\/ASN.2018010050","volume":"29","author":"M Lee","year":"2018","unstructured":"Lee, M. et al. Phosphorylation of acetyl-CoA carboxylase by AMPK reduces renal fibrosis and is essential for the anti-fibrotic effect of metformin. J. Am. Soc. Nephrol. 29, 2326\u20132336 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1049_CR54","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1042\/bst0301064","volume":"30","author":"D Hardie","year":"2002","unstructured":"Hardie, D. & Pan, D. Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem. Soc. Trans. 30, 1064\u20131070 (2002).","journal-title":"Biochem. Soc. Trans."},{"key":"1049_CR55","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bbalip.2008.12.009","volume":"1791","author":"DD Habets","year":"2009","unstructured":"Habets, D. D. et al. Crucial role for LKB1 to AMPK\u03b12 axis in the regulation of CD36-mediated long-chain fatty acid uptake into cardiomyocytes. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1791, 212\u2013219 (2009).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"1049_CR56","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","volume":"13","author":"Y Li","year":"2011","unstructured":"Li, Y. et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 13, 376\u2013388 (2011).","journal-title":"Cell Metab."},{"key":"1049_CR57","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1128\/MCB.00244-16","volume":"36","author":"S-J Kim","year":"2016","unstructured":"Kim, S.-J. et al. AMPK phosphorylates desnutrin\/ATGL and hormone-sensitive lipase to regulate lipolysis and fatty acid oxidation within adipose tissue. Mol. Cell. Biol. 36, 1961\u20131976 (2016).","journal-title":"Mol. Cell. Biol."},{"key":"1049_CR58","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41574-024-00992-y","volume":"20","author":"HT Langer","year":"2024","unstructured":"Langer, H. T., Rohm, M., Goncalves, M. D. & Sylow, L. AMPK as a mediator of tissue preservation: time for a shift in dogma? Nat. Rev. Endocrinol. 20, 526\u2013540 (2024).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1049_CR59","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1210\/endrev\/bnaa023","volume":"42","author":"TE LaMoia","year":"2021","unstructured":"LaMoia, T. E. & Shulman, G. I. Cellular and molecular mechanisms of metformin action. Endocr. Rev. 42, 77\u201396 (2021).","journal-title":"Endocr. Rev."},{"key":"1049_CR60","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00109-011-0748-0","volume":"89","author":"A Salminen","year":"2011","unstructured":"Salminen, A., Hyttinen, J. M. & Kaarniranta, K. AMP-activated protein kinase inhibits NF-\u03baB signaling and inflammation: impact on healthspan and lifespan. J. Mol. Med. 89, 667\u2013676 (2011).","journal-title":"J. Mol. Med."},{"key":"1049_CR61","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.metabol.2018.03.004","volume":"83","author":"X Chen","year":"2018","unstructured":"Chen, X. et al. Activation of AMPK inhibits inflammatory response during hypoxia and reoxygenation through modulating JNK-mediated NF-\u03baB pathway. Metabolism 83, 256\u2013270 (2018).","journal-title":"Metabolism"},{"key":"1049_CR62","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1124\/mol.109.057042","volume":"76","author":"EA Goncharova","year":"2009","unstructured":"Goncharova, E. A. et al. Signal transducer and activator of transcription 3 is required for abnormal proliferation and survival of TSC2-deficient cells: relevance to pulmonary lymphangioleiomyomatosis. Mol. Pharmacol. 76, 766\u2013777 (2009).","journal-title":"Mol. Pharmacol."},{"key":"1049_CR63","doi-asserted-by":"publisher","first-page":"ra109","DOI":"10.1126\/scisignal.aaf8566","volume":"9","author":"C Rutherford","year":"2016","unstructured":"Rutherford, C. et al. Phosphorylation of Janus kinase 1 (JAK1) by AMP-activated protein kinase (AMPK) links energy sensing to anti-inflammatory signaling. Sci. Signal. 9, ra109 (2016).","journal-title":"Sci. Signal."},{"key":"1049_CR64","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.phrs.2017.10.001","volume":"128","author":"C Speirs","year":"2018","unstructured":"Speirs, C., Williams, J. J., Riches, K., Salt, I. P. & Palmer, T. M. Linking energy sensing to suppression of JAK-STAT signalling: a potential route for repurposing AMPK activators? Pharmacol. Res. 128, 88\u2013100 (2018).","journal-title":"Pharmacol. Res."},{"key":"1049_CR65","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nrc2734","volume":"9","author":"H Yu","year":"2009","unstructured":"Yu, H., Pardoll, D. & Jove, R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer 9, 798\u2013809 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"1049_CR66","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.2337\/db14-1225","volume":"64","author":"SB Vasamsetti","year":"2015","unstructured":"Vasamsetti, S. B. et al. Metformin inhibits monocyte-to-macrophage differentiation via AMPK-mediated inhibition of STAT3 activation: potential role in atherosclerosis. Diabetes 64, 2028\u20132041 (2015).","journal-title":"Diabetes"},{"key":"1049_CR67","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/acel.12075","volume":"12","author":"O Moiseeva","year":"2013","unstructured":"Moiseeva, O. et al. Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK\/NF-\u03baB activation. Aging Cell 12, 489\u2013498 (2013).","journal-title":"Aging Cell"},{"key":"1049_CR68","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","volume":"36","author":"K Shimada","year":"2012","unstructured":"Shimada, K. et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36, 401\u2013414 (2012).","journal-title":"Immunity"},{"key":"1049_CR69","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.immuni.2021.05.004","volume":"54","author":"H Xian","year":"2021","unstructured":"Xian, H. et al. Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation. Immunity 54, 1463\u20131477.e11 (2021).","journal-title":"Immunity"},{"key":"1049_CR70","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1158\/1940-6207.CAPR-11-0536","volume":"5","author":"C Algire","year":"2012","unstructured":"Algire, C. et al. Metformin reduces endogenous reactive oxygen species and associated DNA damage. Cancer Prev. Res. 5, 536\u2013543 (2012).","journal-title":"Cancer Prev. Res."},{"key":"1049_CR71","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ebiom.2015.04.002","volume":"2","author":"A Czajka","year":"2015","unstructured":"Czajka, A. et al. Altered mitochondrial function, mitochondrial DNA and reduced metabolic flexibility in patients with diabetic nephropathy. eBioMedicine 2, 499\u2013512 (2015).","journal-title":"eBioMedicine"},{"key":"1049_CR72","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","volume":"6","author":"D Zheng","year":"2020","unstructured":"Zheng, D., Liwinski, T. & Elinav, E. Inflammasome activation and regulation: toward a better understanding of complex mechanisms. Cell Discov. 6, 36 (2020).","journal-title":"Cell Discov."},{"key":"1049_CR73","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201847575","volume":"20","author":"H Van Gorp","year":"2019","unstructured":"Van Gorp, H. & Lamkanfi, M. The emerging roles of inflammasome\u2010dependent cytokines in cancer development. EMBO Rep. 20, e47575 (2019).","journal-title":"EMBO Rep."},{"key":"1049_CR74","first-page":"215","volume":"41","author":"T Tankova","year":"2003","unstructured":"Tankova, T. Current indications for metformin therapy. Rom. J. Intern. Med. 41, 215\u2013225 (2003).","journal-title":"Rom. J. Intern. Med."},{"key":"1049_CR75","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12877-017-0574-5","volume":"17","author":"L Schlender","year":"2017","unstructured":"Schlender, L. et al. Efficacy and safety of metformin in the management of type 2 diabetes mellitus in older adults: a systematic review for the development of recommendations to reduce potentially inappropriate prescribing. BMC Geriatr. 17, 227 (2017).","journal-title":"BMC Geriatr."},{"key":"1049_CR76","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.3390\/ph16091318","volume":"16","author":"V Tocci","year":"2023","unstructured":"Tocci, V. et al. Metformin in gestational diabetes mellitus: to use or not to use, that is the question. Pharmaceuticals 16, 1318 (2023).","journal-title":"Pharmaceuticals"},{"key":"1049_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1215356","volume":"14","author":"DRP Muller","year":"2023","unstructured":"Muller, D. R. P. et al. Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence. Front. Endocrinol. 14, 1215356 (2023).","journal-title":"Front. Endocrinol."},{"key":"1049_CR78","first-page":"658","volume":"19","author":"H Nasri","year":"2014","unstructured":"Nasri, H. & Rafieian-Kopaei, M. Metformin: current knowledge. J. Res. Med. Sci. 19, 658\u2013664 (2014).","journal-title":"J. Res. Med. Sci."},{"key":"1049_CR79","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2337\/dc11-1582","volume":"35","author":"L Reinstatler","year":"2012","unstructured":"Reinstatler, L., Qi, Y. P., Williamson, R. S., Garn, J. V. & Oakley, G. P. Jr Association of biochemical B12 deficiency with metformin therapy and vitamin B12 supplements: the National Health and Nutrition Examination Survey, 1999\u20132006. Diabetes Care 35, 327\u2013333 (2012).","journal-title":"Diabetes Care"},{"key":"1049_CR80","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa042973","volume":"352","author":"CA Crowther","year":"2005","unstructured":"Crowther, C. A. et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N. Engl. J. Med. 352, 2477\u20132486 (2005).","journal-title":"N. Engl. J. Med."},{"key":"1049_CR81","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.diabet.2013.02.006","volume":"39","author":"AJ Scheen","year":"2013","unstructured":"Scheen, A. J. & Paquot, N. Metformin revisited: a critical review of the benefit\u2013risk balance in at-risk patients with type 2 diabetes. Diabetes Metab. 39, 179\u2013190 (2013).","journal-title":"Diabetes Metab."},{"key":"1049_CR82","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ebiom.2018.08.047","volume":"35","author":"L Nguyen","year":"2018","unstructured":"Nguyen, L., Chan, S. Y. & Teo, A. K. K. Metformin from mother to unborn child \u2014 are there unwarranted effects? eBioMedicine 35, 394\u2013404 (2018).","journal-title":"eBioMedicine"},{"key":"1049_CR83","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.fertnstert.2004.11.051","volume":"83","author":"E Vanky","year":"2005","unstructured":"Vanky, E., Zahlsen, K., Spigset, O. & Carlsen, S. M. Placental passage of metformin in women with polycystic ovary syndrome. Fertil. Steril. 83, 1575\u20131578 (2005).","journal-title":"Fertil. Steril."},{"key":"1049_CR84","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11892-003-0022-0","volume":"3","author":"CJ Glueck","year":"2003","unstructured":"Glueck, C. J., Goldenberg, N., Streicher, P. & Wang, P. Metformin and gestational diabetes. Curr. Diab. Rep. 3, 303\u2013312 (2003).","journal-title":"Curr. Diab. Rep."},{"key":"1049_CR85","doi-asserted-by":"publisher","first-page":"k2477","DOI":"10.1136\/bmj.k2477","volume":"361","author":"JE Given","year":"2018","unstructured":"Given, J. E. et al. Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case\u2013control study. BMJ 361, k2477 (2018).","journal-title":"BMJ"},{"key":"1049_CR86","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/1471-0528.12964","volume":"122","author":"H Ij\u00e4s","year":"2015","unstructured":"Ij\u00e4s, H., V\u00e4\u00e4r\u00e4sm\u00e4ki, M., Saarela, T., Keravuo, R. & Raudaskoski, T. A follow-up of a randomised study of metformin and insulin in gestational diabetes mellitus: growth and development of the children at the age of 18 months. Br. J. Obstet. Gynaecol. 122, 994\u20131000 (2015).","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"1049_CR87","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.2337\/dc11-0660","volume":"34","author":"JA Rowan","year":"2011","unstructured":"Rowan, J. A. et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes Care 34, 2279\u20132284 (2011).","journal-title":"Diabetes Care"},{"key":"1049_CR88","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1900\/RDS.2008.5.95","volume":"5","author":"K Tertti","year":"2008","unstructured":"Tertti, K., Ekblad, U., Vahlberg, T. & R\u00f6nnemaa, T. Comparison of metformin and insulin in the treatment of gestational diabetes: a retrospective, case\u2013control study. Rev. Diabet. Stud. 5, 95\u2013101 (2008).","journal-title":"Rev. Diabet. Stud."},{"key":"1049_CR89","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ejogrb.2011.11.018","volume":"160","author":"P Gandhi","year":"2012","unstructured":"Gandhi, P., Bustani, R., Madhuvrata, P. & Farrell, T. Introduction of metformin for gestational diabetes mellitus in clinical practice: has it had an impact? Eur. J. Obstet. Gynecol. Reprod. Biol. 160, 147\u2013150 (2012).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"1049_CR90","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.diabres.2016.04.051","volume":"116","author":"RT McGrath","year":"2016","unstructured":"McGrath, R. T., Glastras, S. J., Hocking, S. & Fulcher, G. R. Use of metformin earlier in pregnancy predicts supplemental insulin therapy in women with gestational diabetes. Diabetes Res. Clin. Pract. 116, 96\u201399 (2016).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1049_CR91","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.2337\/dc21-0327","volume":"44","author":"J Estrella","year":"2021","unstructured":"Estrella, J., Wiley, V., Simmons, D., Hng, T. M. & McLean, M. Effect of maternal metformin treatment in pregnancy on neonatal metabolism: evidence from newborn metabolic screening. Diabetes Care 44, 2536\u20132541 (2021).","journal-title":"Diabetes Care"},{"key":"1049_CR92","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1080\/14767058.2018.1550480","volume":"33","author":"M Bashir","year":"2020","unstructured":"Bashir, M. et al. Metformin-treated-GDM has lower risk of macrosomia compared to diet-treated GDM \u2014 a retrospective cohort study. J. Matern. Fetal Neonatal Med. 33, 2366\u20132371 (2020).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"1049_CR93","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ejogrb.2020.09.037","volume":"254","author":"L Pazzagli","year":"2020","unstructured":"Pazzagli, L., Abdi, L., Kieler, H. & Cesta, C. E. Metformin versus insulin use for treatment of gestational diabetes and delivery by caesarean section: a nationwide Swedish cohort study. Eur. J. Obstet. Gynecol. Reprod. Biol. 254, 271\u2013276 (2020).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"1049_CR94","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1002\/pds.4907","volume":"28","author":"SN Landi","year":"2019","unstructured":"Landi, S. N. et al. Comparative effectiveness of metformin versus insulin for gestational diabetes in New Zealand. Pharmacoepidemiol. Drug. Saf. 28, 1609\u20131619 (2019).","journal-title":"Pharmacoepidemiol. Drug. Saf."},{"key":"1049_CR95","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.diabres.2018.01.002","volume":"137","author":"Vanlalhruaii","year":"2018","unstructured":"Vanlalhruaii et al. How safe is metformin when initiated in early pregnancy? A retrospective 5-year study of pregnant women with gestational diabetes mellitus from India. Diabetes Res. Clin. Pract. 137, 47\u201355 (2018).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1049_CR96","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.dsx.2018.01.003","volume":"12","author":"MO Khin","year":"2018","unstructured":"Khin, M. O., Gates, S. & Saravanan, P. Predictors of metformin failure in gestational diabetes mellitus (GDM). Diabetes Metab. Syndr. 12, 405\u2013410 (2018).","journal-title":"Diabetes Metab. Syndr."},{"key":"1049_CR97","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1515\/jpm-2020-0435","volume":"49","author":"KM Herrera","year":"2021","unstructured":"Herrera, K. M. et al. Risk of metformin failure in the treatment of women with gestational diabetes. J. Perinat. Med. 49, 1084\u20131088 (2021).","journal-title":"J. Perinat. Med."},{"key":"1049_CR98","doi-asserted-by":"publisher","unstructured":"Benido Silva, V. et al. Predictors of metformin monotherapy failure in gestational diabetes mellitus. Endocr. Connect. https:\/\/doi.org\/10.1530\/ec-21-0540 (2022).","DOI":"10.1530\/ec-21-0540"},{"key":"1049_CR99","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/j.1464-5491.2009.02780.x","volume":"26","author":"J Balani","year":"2009","unstructured":"Balani, J., Hyer, S. L., Rodin, D. A. & Shehata, H. Pregnancy outcomes in women with gestational diabetes treated with metformin or insulin: a case\u2013control study. Diabet. Med. 26, 798\u2013802 (2009).","journal-title":"Diabet. Med."},{"key":"1049_CR100","doi-asserted-by":"publisher","first-page":"491","DOI":"10.4103\/0019-5359.58878","volume":"63","author":"L Rai","year":"2009","unstructured":"Rai, L., Meenakshi, D. & Kamath, A. Metformin \u2014 a convenient alternative to insulin for Indian women with diabetes in pregnancy. Indian J. Med. Sci. 63, 491\u2013497 (2009).","journal-title":"Indian J. Med. Sci."},{"key":"1049_CR101","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1258\/om.2012.110092","volume":"5","author":"J Balani","year":"2012","unstructured":"Balani, J., Hyer, S., Johnson, A. & Shehata, H. Pregnancy outcomes after metformin treatment for gestational diabetes: a case\u2013control study. Obstet. Med. 5, 78\u201382 (2012).","journal-title":"Obstet. Med."},{"key":"1049_CR102","doi-asserted-by":"publisher","first-page":"623","DOI":"10.4103\/ijmr.IJMR_1358_15","volume":"145","author":"N Singh","year":"2017","unstructured":"Singh, N., Madhu, M., Vanamail, P., Malik, N. & Kumar, S. Efficacy of metformin in improving glycaemic control & perinatal outcome in gestational diabetes mellitus: a non-randomized study. Indian J. Med. Res. 145, 623\u2013628 (2017).","journal-title":"Indian J. Med. Res."},{"key":"1049_CR103","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4103\/2230-8210.149317","volume":"19","author":"AK Singh","year":"2015","unstructured":"Singh, A. K. & Singh, R. Metformin in gestational diabetes: an emerging contender. Indian J. Endocrinol. Metab. 19, 236 (2015).","journal-title":"Indian J. Endocrinol. Metab."},{"key":"1049_CR104","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/j.1464-5491.2011.03361.x","volume":"28","author":"JE Goh","year":"2011","unstructured":"Goh, J. E., Sadler, L. & Rowan, J. Metformin for gestational diabetes in routine clinical practice. Diabet. Med. 28, 1082\u20131087 (2011).","journal-title":"Diabet. Med."},{"key":"1049_CR105","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3889\/oamjms.2018.200","volume":"6","author":"S Simeonova-Krstevska","year":"2018","unstructured":"Simeonova-Krstevska, S. et al. Maternal and neonatal outcomes in pregnant women with gestational diabetes mellitus treated with diet, metformin or insulin. Open Access Macedonian J. Med. Sci. 6, 803 (2018).","journal-title":"Open Access Macedonian J. Med. Sci."},{"key":"1049_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-018-3540-1","volume":"11","author":"SJ Christian","year":"2018","unstructured":"Christian, S. J. et al. Metformin or insulin: logical treatment in women with gestational diabetes in the Middle East, our experience. BMC Res. Notes 11, 426 (2018).","journal-title":"BMC Res. Notes"},{"key":"1049_CR107","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/ajo.12018","volume":"53","author":"A Corbould","year":"2013","unstructured":"Corbould, A. et al. Fasting blood glucose predicts response to extended-release metformin in gestational diabetes mellitus. Aust. N. Z. J. Obstet. Gynaecol. 53, 125\u2013129 (2013).","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"1049_CR108","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1119134","volume":"14","author":"MM Brzozowska","year":"2023","unstructured":"Brzozowska, M. M. et al. Predictors for pharmacological therapy and perinatal outcomes with metformin treatment in women with gestational diabetes. Front. Endocrinol. 14, 1119134 (2023).","journal-title":"Front. Endocrinol."},{"key":"1049_CR109","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1055\/s-0039-1700796","volume":"41","author":"MLR Souza","year":"2019","unstructured":"Souza, M. L. R. et al. Factors associated with the need for insulin as a complementary treatment to metformin in gestational diabetes mellitus. Rev. Bras. Ginecol. Obstet. 41, 697\u2013702 (2019).","journal-title":"Rev. Bras. Ginecol. Obstet."},{"key":"1049_CR110","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/cpt.1749","volume":"107","author":"DL Shuster","year":"2020","unstructured":"Shuster, D. L. et al. Pharmacodynamics of glyburide, metformin, and glyburide\/metformin combination therapy in the treatment of gestational diabetes mellitus. Clin. Pharmacol. Ther. 107, 1362\u20131372 (2020).","journal-title":"Clin. Pharmacol. Ther."},{"key":"1049_CR111","first-page":"762","volume":"326","author":"WM Hague","year":"2003","unstructured":"Hague, W. M., Davoren, P. M., Oliver, J. & Rowan, J. Contraindications to use of metformin. Metformin may be useful in gestational diabetes. BMJ Open 326, 762 (2003).","journal-title":"BMJ Open"},{"key":"1049_CR112","doi-asserted-by":"publisher","first-page":"34.e31","DOI":"10.1016\/j.ajog.2013.03.022","volume":"209","author":"CP Spaulonci","year":"2013","unstructured":"Spaulonci, C. P., Bernardes, L. S., Trindade, T. C., Zugaib, M. & Francisco, R. P. Randomized trial of metformin vs insulin in the management of gestational diabetes. Am. J. Obstet. Gynecol. 209, 34.e31\u201337 (2013).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1049_CR113","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/dom.12017","volume":"15","author":"K Tertti","year":"2013","unstructured":"Tertti, K., Ekblad, U., Koskinen, P., Vahlberg, T. & R\u00f6nnemaa, T. Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin. Diabetes Obes. Metab. 15, 246\u2013251 (2013).","journal-title":"Diabetes Obes. Metab."},{"key":"1049_CR114","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.diabres.2014.10.001","volume":"107","author":"J Ainuddin","year":"2015","unstructured":"Ainuddin, J., Karim, N., Hasan, A. A. & Naqvi, S. A. Metformin versus insulin treatment in gestational diabetes in pregnancy in a developing country: a randomized control trial. Diabetes Res. Clin. Pract. 107, 290\u2013299 (2015).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1049_CR115","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.diabres.2012.09.031","volume":"98","author":"S Niromanesh","year":"2012","unstructured":"Niromanesh, S. et al. Metformin compared with insulin in the management of gestational diabetes mellitus: a randomized clinical trial. Diabetes Res. Clin. Pract. 98, 422\u2013429 (2012).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1049_CR116","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00592-014-0570-6","volume":"51","author":"K Tertti","year":"2014","unstructured":"Tertti, K., Laine, K., Ekblad, U., Rinne, V. & R\u00f6nnemaa, T. The degree of fetal metformin exposure does not influence fetal outcome in gestational diabetes mellitus. Acta Diabetol. 51, 731\u2013738 (2014).","journal-title":"Acta Diabetol."},{"key":"1049_CR117","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","volume":"358","author":"JA Rowan","year":"2008","unstructured":"Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R. & Moore, M. P. Metformin versus insulin for the treatment of gestational diabetes. N. Engl. J. Med. 358, 2003\u20132015 (2008).","journal-title":"N. Engl. J. Med."},{"key":"1049_CR118","first-page":"1011","volume":"52","author":"LE Moore","year":"2007","unstructured":"Moore, L. E. et al. Metformin and insulin in the management of gestational diabetes mellitus: preliminary results of a comparison. J. Reprod. Med. 52, 1011\u20131015 (2007).","journal-title":"J. Reprod. Med."},{"key":"1049_CR119","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/j.1471-0528.2010.02763.x","volume":"118","author":"H Ij\u00e4s","year":"2011","unstructured":"Ij\u00e4s, H. et al. Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study. Br. J. Obstet. Gynaecol. 118, 880\u2013885 (2011).","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"1049_CR120","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/jog.12950","volume":"42","author":"S Ashoush","year":"2016","unstructured":"Ashoush, S., El-Said, M., Fathi, H. & Abdelnaby, M. Identification of metformin poor responders, requiring supplemental insulin, during randomization of metformin versus insulin for the control of gestational diabetes mellitus. J. Obstet. Gynaecol. Res. 42, 640\u2013647 (2016).","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"1049_CR121","first-page":"227","volume":"67","author":"A Zawiejska","year":"2016","unstructured":"Zawiejska, A., Wender-Ozegowska, E., Grewling-Szmit, K., Brazert, M. & Brazert, J. Short-term antidiabetic treatment with insulin or metformin has a similar impact on the components of metabolic syndrome in women with gestational diabetes mellitus requiring antidiabetic agents: results of a prospective, randomised study. J. Physiol. Pharmacol. 67, 227\u2013233 (2016).","journal-title":"J. Physiol. Pharmacol."},{"key":"1049_CR122","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1002\/jcp.27238","volume":"234","author":"N Ghomian","year":"2019","unstructured":"Ghomian, N. et al. The efficacy of metformin compared with insulin in regulating blood glucose levels during gestational diabetes mellitus: a randomized clinical trial. J. Cell. Physiol. 234, 4695\u20134701 (2019).","journal-title":"J. Cell. Physiol."},{"key":"1049_CR123","first-page":"384","volume":"28","author":"JA Hasan","year":"2012","unstructured":"Hasan, J. A., Karim, N. & Sheikh, Z. Metformin prevents macrosomia and neonatal morbidity in gestational diabetes. Pak. J. Med. Sci. 28, 384\u2013389 (2012).","journal-title":"Pak. J. Med. Sci."},{"key":"1049_CR124","first-page":"327","volume":"4","author":"E Mesdaghinia","year":"2013","unstructured":"Mesdaghinia, E. et al. Comparison of newborn outcomes in women with gestational diabetes mellitus treated with metformin or insulin: a randomised blinded trial. Int. J. Prev. Med. 4, 327\u2013333 (2013).","journal-title":"Int. J. Prev. Med."},{"key":"1049_CR125","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3480629","volume":"2016","author":"HS Saleh","year":"2016","unstructured":"Saleh, H. S., Abdelsalam, W. A., Mowafy, H. E. & Abd ElHameid, A. A. Could metformin manage gestational diabetes mellitus instead of insulin? Int. J. Reprod. Med. 2016, 3480629 (2016).","journal-title":"Int. J. Reprod. Med."},{"key":"1049_CR126","doi-asserted-by":"publisher","first-page":"517.e1","DOI":"10.1016\/j.ajog.2021.04.229","volume":"225","author":"MJ Pic\u00f3n-C\u00e9sar","year":"2021","unstructured":"Pic\u00f3n-C\u00e9sar, M. J. et al. Metformin for gestational diabetes study: metformin vs insulin in gestational diabetes: glycemic control and obstetrical and perinatal outcomes: randomized prospective trial. Am. J. Obstet. Gynecol. 225, 517.e1\u2013517.e17 (2021).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1049_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-020-03077-6","volume":"20","author":"MS Huhtala","year":"2020","unstructured":"Huhtala, M. S., Tertti, K., Juhila, J., Sorsa, T. & R\u00f6nnemaa, T. Metformin and insulin treatment of gestational diabetes: effects on inflammatory markers and IGF-binding protein-1 \u2014 secondary analysis of a randomized controlled trial. BMC Pregnancy Childbirth 20, 401 (2020).","journal-title":"BMC Pregnancy Childbirth"},{"key":"1049_CR128","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.diabres.2018.03.003","volume":"139","author":"MW Osman","year":"2018","unstructured":"Osman, M. W. et al. The effects of metformin on maternal haemodynamics in gestational diabetes mellitus: a pilot study. Diabetes Res. Clin. Pract. 139, 170\u2013178 (2018).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1049_CR129","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.diabres.2018.09.014","volume":"146","author":"MS Huhtala","year":"2018","unstructured":"Huhtala, M. S., Tertti, K., Pellonper\u00e4, O. & R\u00f6nnemaa, T. Amino acid profile in women with gestational diabetes mellitus treated with metformin or insulin. Diabetes Res. Clin. Pract. 146, 8\u201317 (2018).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1049_CR130","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/jama.2023.19869","volume":"330","author":"F Dunne","year":"2023","unstructured":"Dunne, F. et al. Early metformin in gestational diabetes: a randomized clinical trial. JAMA 330, 1547\u20131556 (2023).","journal-title":"JAMA"},{"key":"1049_CR131","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2337\/dc16-2307","volume":"40","author":"Z Nachum","year":"2017","unstructured":"Nachum, Z. et al. Glyburide versus metformin and their combination for the treatment of gestational diabetes mellitus: a randomized controlled study. Diabetes Care 40, 332\u2013337 (2017).","journal-title":"Diabetes Care"},{"key":"1049_CR132","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/AOG.0b013e3181c52132","volume":"115","author":"LE Moore","year":"2010","unstructured":"Moore, L. E., Clokey, D., Rappaport, V. J. & Curet, L. B. Metformin compared with glyburide in gestational diabetes: a randomized controlled trial. Obstet. Gynecol. 115, 55\u201359 (2010).","journal-title":"Obstet. Gynecol."},{"key":"1049_CR133","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2017-000456","volume":"6","author":"JA Rowan","year":"2018","unstructured":"Rowan, J. A. et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7\u20139 years of age. BMJ Open Diabetes Res. Care 6, e000456 (2018).","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"1049_CR134","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/DBP.0000000000000230","volume":"36","author":"K Tertti","year":"2015","unstructured":"Tertti, K., Eskola, E., R\u00f6nnemaa, T. & Haataja, L. Neurodevelopment of two-year-old children exposed to metformin and insulin in gestational diabetes mellitus. J. Dev. Behav. Pediatr. 36, 752\u2013757 (2015).","journal-title":"J. Dev. Behav. Pediatr."},{"key":"1049_CR135","doi-asserted-by":"publisher","first-page":"457.e451","DOI":"10.1016\/j.ajog.2010.06.044","volume":"203","author":"JS Dhulkotia","year":"2010","unstructured":"Dhulkotia, J. S., Ola, B., Fraser, R. & Farrell, T. Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis. Am. J. Obstet. Gynecol. 203, 457.e451\u2013459 (2010).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1049_CR136","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064585","volume":"8","author":"J Gui","year":"2013","unstructured":"Gui, J., Liu, Q. & Feng, L. Metformin vs insulin in the management of gestational diabetes: a meta-analysis. PLoS ONE 8, e64585 (2013).","journal-title":"PLoS ONE"},{"key":"1049_CR137","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/bcp.12672","volume":"80","author":"LP Zhao","year":"2015","unstructured":"Zhao, L. P. et al. Metformin versus insulin for gestational diabetes mellitus: a meta-analysis. Br. J. Clin. Pharmacol. 80, 1224\u20131234 (2015).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"1049_CR138","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.diabres.2015.05.017","volume":"109","author":"P Kitwitee","year":"2015","unstructured":"Kitwitee, P. et al. Metformin for the treatment of gestational diabetes: an updated meta-analysis. Diabetes Res. Clin. Pract. 109, 521\u2013532 (2015).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1049_CR139","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1080\/14767058.2016.1228061","volume":"30","author":"Y Feng","year":"2017","unstructured":"Feng, Y. & Yang, H. Metformin \u2014 a potentially effective drug for gestational diabetes mellitus: a systematic review and meta-analysis. J. Matern. Fetal Neonatal Med. 30, 1874\u20131881 (2017).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"1049_CR140","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/OGX.0000000000000671","volume":"74","author":"KC Bishop","year":"2019","unstructured":"Bishop, K. C. et al. Pharmacologic treatment of diabetes in pregnancy. Obstet. Gynecol. Surv. 74, 289\u2013297 (2019).","journal-title":"Obstet. Gynecol. Surv."},{"key":"1049_CR141","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12964","volume":"21","author":"SAR Doi","year":"2020","unstructured":"Doi, S. A. R. et al. Metformin in pregnancy to avert gestational diabetes in women at high risk: meta-analysis of randomized controlled trials. Obes. Rev. 21, e12964 (2020).","journal-title":"Obes. Rev."},{"key":"1049_CR142","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015557","volume":"7","author":"D Farrar","year":"2017","unstructured":"Farrar, D. et al. Treatments for gestational diabetes: a systematic review and meta-analysis. BMJ Open 7, e015557 (2017).","journal-title":"BMJ Open"},{"key":"1049_CR143","first-page":"h102","volume":"350","author":"M Balsells","year":"2015","unstructured":"Balsells, M. et al. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ Open 350, h102 (2015).","journal-title":"BMJ Open"},{"key":"1049_CR144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11892-019-1199-1","volume":"19","author":"JF Plows","year":"2019","unstructured":"Plows, J. F., Reynolds, C. M., Vickers, M. H., Baker, P. N. & Stanley, J. L. Nutritional supplementation for the prevention and\/or treatment of gestational diabetes mellitus. Curr. Diabetes Rep. 19, 1\u201315 (2019).","journal-title":"Curr. Diabetes Rep."},{"key":"1049_CR145","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.diabres.2018.04.015","volume":"145","author":"R Corcoy","year":"2018","unstructured":"Corcoy, R., Balsells, M., Garc\u00eda-Patterson, A., Shmueli, A. & Hadar, E. Pharmacotherapy for hyperglycemia in pregnancy \u2014 do oral agents have a place? Diabetes Res. Clin. Pract. 145, 51\u201358 (2018).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1049_CR146","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.diabres.2013.12.056","volume":"104","author":"DF Su","year":"2014","unstructured":"Su, D. F. & Wang, X. Y. Metformin vs insulin in the management of gestational diabetes: a systematic review and meta-analysis. Diabetes Res. Clin. Pract. 104, 353\u2013357 (2014).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1049_CR147","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/dme.13150","volume":"34","author":"S Butalia","year":"2017","unstructured":"Butalia, S. et al. Short\u2010 and long\u2010term outcomes of metformin compared with insulin alone in pregnancy: a systematic review and meta\u2010analysis. Diabet. Med. 34, 27\u201336 (2017).","journal-title":"Diabet. Med."},{"key":"1049_CR148","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007939","volume":"96","author":"H-L Liang","year":"2017","unstructured":"Liang, H.-L., Ma, S.-J., Xiao, Y.-N. & Tan, H.-Z. Comparative efficacy and safety of oral antidiabetic drugs and insulin in treating gestational diabetes mellitus: an updated PRISMA-compliant network meta-analysis. Medicine 96, e7939 (2017).","journal-title":"Medicine"},{"key":"1049_CR149","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003126","volume":"17","author":"JL Tarry-Adkins","year":"2020","unstructured":"Tarry-Adkins, J. L., Aiken, C. E. & Ozanne, S. E. Comparative impact of pharmacological treatments for gestational diabetes on neonatal anthropometry independent of maternal glycaemic control: a systematic review and meta-analysis. PLoS Med. 17, e1003126 (2020).","journal-title":"PLoS Med."},{"key":"1049_CR150","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000515893","volume":"86","author":"X Wang","year":"2021","unstructured":"Wang, X., Liu, W., Chen, H. & Chen, Q. Comparison of insulin, metformin, and glyburide on perinatal complications of gestational diabetes mellitus: a systematic review and meta-analysis. Gynecol. Obstet. Invest. 86, 218\u2013230 (2021).","journal-title":"Gynecol. Obstet. Invest."},{"key":"1049_CR151","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/09513590.2021.2015761","volume":"38","author":"C Li","year":"2022","unstructured":"Li, C. et al. Comparison of the effectiveness and safety of insulin and oral hypoglycemic drugs in the treatment of gestational diabetes mellitus: a meta-analysis of 26 randomized controlled trials. Gynecol. Endocrinol. 38, 303\u2013309 (2022).","journal-title":"Gynecol. Endocrinol."},{"key":"1049_CR152","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-021-00865-9","volume":"21","author":"DQ Yu","year":"2021","unstructured":"Yu, D. Q. et al. Glycemic control and neonatal outcomes in women with gestational diabetes mellitus treated using glyburide, metformin, or insulin: a pairwise and network meta-analysis. BMC Endocr. Disord. 21, 199 (2021).","journal-title":"BMC Endocr. Disord."},{"key":"1049_CR153","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.980578","volume":"10","author":"T Wang","year":"2022","unstructured":"Wang, T. et al. Efficacy and safety of hypoglycemic agents on gestational diabetes mellitus in women: a Bayesian network analysis of randomized controlled trials. Front. Public. Health 10, 980578 (2022).","journal-title":"Front. Public. Health"},{"key":"1049_CR154","first-page":"CD012327","volume":"8","author":"R Martis","year":"2018","unstructured":"Martis, R. et al. Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews. Cochrane Database Syst. Rev. 8, CD012327 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1049_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107924","volume":"158","author":"C Chatzakis","year":"2019","unstructured":"Chatzakis, C. et al. Prevention of gestational diabetes mellitus in overweight or obese pregnant women: a network meta-analysis. Diabetes Res. Clin. Pract. 158, 107924 (2019).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1049_CR156","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9804708","volume":"2019","author":"L Guo","year":"2019","unstructured":"Guo, L. et al. Comparative efficacy and safety of metformin, glyburide, and insulin in treating gestational diabetes mellitus: a meta-analysis. J. Diabetes Res. 2019, 9804708 (2019).","journal-title":"J. Diabetes Res."},{"key":"1049_CR157","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/jcpt.13503","volume":"47","author":"K He","year":"2022","unstructured":"He, K. et al. The efficacy and safety of metformin alone or as an add-on therapy to insulin in pregnancy with GDM or T2DM: a systematic review and meta-analysis of 21 randomized controlled trials. J. Clin. Pharm. Ther. 47, 168\u2013177 (2022).","journal-title":"J. Clin. Pharm. Ther."},{"key":"1049_CR158","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002848","volume":"16","author":"JL Tarry-Adkins","year":"2019","unstructured":"Tarry-Adkins, J. L., Aiken, C. E. & Ozanne, S. E. Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: a systematic review and meta-analysis. PLoS Med. 16, e1002848 (2019).","journal-title":"PLoS Med."},{"key":"1049_CR159","doi-asserted-by":"publisher","first-page":"367.e1","DOI":"10.1016\/j.ajog.2018.06.013","volume":"219","author":"LA Barbour","year":"2018","unstructured":"Barbour, L. A. et al. A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes. Am. J. Obstet. Gynecol. 219, 367.e1\u2013367.e7 (2018).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1049_CR160","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s00404-019-05124-w","volume":"299","author":"Q Xu","year":"2019","unstructured":"Xu, Q. & Xie, Q. Long-term effects osf prenatal exposure to metformin on the health of children based on follow-up studies of randomized controlled trials: a systematic review and meta-analysis. Arch. Gynecol. Obstet. 299, 1295\u20131303 (2019).","journal-title":"Arch. Gynecol. Obstet."},{"key":"1049_CR161","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.diabres.2018.07.002","volume":"144","author":"XM Zhen","year":"2018","unstructured":"Zhen, X. M., Li, X. & Chen, C. Longer-term outcomes in offspring of GDM mothers treated with metformin versus insulin. Diabetes Res. Clin. Pract. 144, 82\u201392 (2018).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1049_CR162","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-036981","volume":"10","author":"A Mousa","year":"2020","unstructured":"Mousa, A. et al. Metformin in Pregnancy Study (MiPS): protocol for a systematic review with individual patient data meta-analysis. BMJ Open 10, e036981 (2020).","journal-title":"BMJ Open"},{"key":"1049_CR163","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1515\/jpem-2001-0803","volume":"14","author":"D Dabelea","year":"2001","unstructured":"Dabelea, D. & Pettitt, D. J. Intrauterine diabetic environment confers risks for type 2 diabetes mellitus and obesity in the offspring, in addition to genetic susceptibility. J. Pediatr. Endocrinol. Metab. 14, 1085\u20131091 (2001).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"1049_CR164","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.bcp.2004.04.003","volume":"68","author":"BA Kefas","year":"2004","unstructured":"Kefas, B. A. et al. Metformin-induced stimulation of AMP-activated protein kinase in \u03b2-cells impairs their glucose responsiveness and can lead to apoptosis. Biochem. Pharmacol. 68, 409\u2013416 (2004).","journal-title":"Biochem. Pharmacol."},{"key":"1049_CR165","doi-asserted-by":"publisher","first-page":"E1023","DOI":"10.1152\/ajpendo.00532.2003","volume":"286","author":"I Leclerc","year":"2004","unstructured":"Leclerc, I. et al. Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion. Am. J. Physiol. Endocrinol. Metab. 286, E1023\u2013E1031 (2004).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1049_CR166","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1093\/humrep\/des264","volume":"27","author":"P Tartarin","year":"2012","unstructured":"Tartarin, P. et al. Metformin exposure affects human and mouse fetal testicular cells. Hum. Reprod. 27, 3304\u20133314 (2012).","journal-title":"Hum. Reprod."},{"key":"1049_CR167","doi-asserted-by":"publisher","first-page":"254","DOI":"10.2337\/diacare.29.02.06.dc05-1558","volume":"29","author":"SL Bowker","year":"2006","unstructured":"Bowker, S. L., Majumdar, S. R., Veugelers, P. & Johnson, J. A. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 29, 254\u2013258 (2006).","journal-title":"Diabetes Care"},{"key":"1049_CR168","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/bcp.13780","volume":"85","author":"S Amin","year":"2019","unstructured":"Amin, S., Lux, A. & O\u2019Callaghan, F. The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth. Br. J. Clin. Pharmacol. 85, 37\u201346 (2019).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"1049_CR169","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.diabres.2013.12.031","volume":"104","author":"M Masini","year":"2014","unstructured":"Masini, M. et al. Prevention by metformin of alterations induced by chronic exposure to high glucose in human islet beta cells is associated with preserved ATP\/ADP ratio. Diabetes Res. Clin. Pract. 104, 163\u2013170 (2014).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1049_CR170","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.cell.2013.02.035","volume":"153","author":"F Cabreiro","year":"2013","unstructured":"Cabreiro, F. et al. Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell 153, 228\u2013239 (2013).","journal-title":"Cell"},{"key":"1049_CR171","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1365-2796.2007.01809.x","volume":"261","author":"DJ Barker","year":"2007","unstructured":"Barker, D. J. The origins of the developmental origins theory. J. Intern. Med. 261, 412\u2013417 (2007).","journal-title":"J. Intern. Med."},{"key":"1049_CR172","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1097\/AOG.0000000000002501","volume":"131","author":"American College of Obstetricians and Gynecologists.","year":"2018","unstructured":"American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 190: gestational diabetes mellitus. Obstet. Gynecol. 131, e49\u2013e64 (2018).","journal-title":"Obstet. Gynecol."},{"key":"1049_CR173","unstructured":"Nankervis, A. et al. ADIPS Consensus Guidelines for the Testing and Diagnosis of Hyperglycaemia in Pregnancy in Australia and New Zealand (Australasian Diabetes in Pregnancy Society, 2014)."},{"key":"1049_CR174","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-5996-2-27","volume":"2","author":"CA Negrato","year":"2010","unstructured":"Negrato, C. A. et al. Dysglycemias in pregnancy: from diagnosis to treatment. Brazilian Consensus Statement. Diabetol. Metab. Syndr. 2, 1\u201314 (2010).","journal-title":"Diabetol. Metab. Syndr."},{"key":"1049_CR175","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1097\/AOG.0000000000001383","volume":"127","author":"LM Harper","year":"2016","unstructured":"Harper, L. M. et al. Carpenter\u2013Coustan compared with National Diabetes Data Group criteria for diagnosing gestational diabetes. Obstet. Gynecol. 127, 893\u2013898 (2016).","journal-title":"Obstet. Gynecol."},{"key":"1049_CR176","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.jcjd.2017.10.003","volume":"42","author":"Z Punthakee","year":"2018","unstructured":"Punthakee, Z., Goldenberg, R. & Katz, P. Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can. J. Diabetes 42, S10\u2013S15 (2018).","journal-title":"Can. J. Diabetes"},{"key":"1049_CR177","first-page":"15","volume":"60","author":"V Seshiah","year":"2012","unstructured":"Seshiah, V. et al. Diagnosis of gestational diabetes mellitus in the community. J. Assoc. Physicians India 60, 15\u201317 (2012).","journal-title":"J. Assoc. Physicians India"},{"key":"1049_CR178","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"L Ryd\u00e9n","year":"2013","unstructured":"Ryd\u00e9n, L. et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur. Heart J. 34, 3035\u20133087 (2013).","journal-title":"Eur. Heart J."},{"key":"1049_CR179","doi-asserted-by":"publisher","first-page":"676","DOI":"10.2337\/dc10-0719","volume":"33","author":"BE Metzger","year":"2010","unstructured":"Metzger, B. E. et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33, 676\u2013682 (2010).","journal-title":"Diabetes Care"},{"key":"1049_CR180","doi-asserted-by":"publisher","first-page":"782","DOI":"10.4239\/wjd.v6.i6.782","volume":"6","author":"MM Agarwal","year":"2015","unstructured":"Agarwal, M. M. Gestational diabetes mellitus: an update on the current international diagnostic criteria. World J. Diabetes 6, 782\u2013791 (2015).","journal-title":"World J. Diabetes"},{"key":"1049_CR181","doi-asserted-by":"publisher","first-page":"253.e1","DOI":"10.1016\/j.ajog.2011.06.026","volume":"205","author":"EK Berggren","year":"2011","unstructured":"Berggren, E. K., Boggess, K. A., Stuebe, A. M. & Jonsson Funk, M. National Diabetes Data Group vs Carpenter\u2013Coustan criteria to diagnose gestational diabetes. Am. J. Obstet. Gynecol. 205, 253.e1\u20137 (2011).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1049_CR182","doi-asserted-by":"publisher","first-page":"107","DOI":"10.15277\/bjdvd.2015.029","volume":"15","author":"J Webber","year":"2015","unstructured":"Webber, J., Charlton, M. & Johns, N. Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period (NG3). Br. J. Diabetes 15, 107\u2013111 (2015).","journal-title":"Br. J. Diabetes"},{"key":"1049_CR183","unstructured":"World Health Organization. Classification of Diabetes Mellitus. Report No. 9241515708 (World Health Organizaion, 2019)."},{"key":"1049_CR184","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1016\/S0020-7292(15)30007-2","volume":"131","author":"M Hod","year":"2015","unstructured":"Hod, M. et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int. J. Gynaecol. Obstet. 131, S173\u2013S211 (2015).","journal-title":"Int. J. Gynaecol. Obstet."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-01049-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-01049-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-01049-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T01:01:46Z","timestamp":1736989306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-01049-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":184,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1049"],"URL":"https:\/\/doi.org\/10.1038\/s41574-024-01049-w","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]},"assertion":[{"value":"3 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}